Using electrical stimulation to help COPD patients breathe and move better
Electrical Stimulation for Respiratory and Leg Muscles Impact on Pulmonary Function and Leg Restless Syndrome in COPD Patients
This study is testing if using electrical stimulation on the breathing and leg muscles can help people with COPD breathe and move better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 40 Years to 65 Years |
| Sex | All |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Dokki) |
| Trial ID | NCT06670443 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of electrical neuromuscular stimulation applied to the respiratory and leg muscles of patients with Chronic Obstructive Pulmonary Disease (COPD). The intervention involves placing electrode patches over specific muscle groups to stimulate them, with a structured protocol for ramping up and down the intensity of stimulation. The goal is to assess improvements in respiratory function and mobility in COPD patients. Participants will be divided into experimental and control groups to evaluate the efficacy of this approach.
Who should consider this trial
Good fit: Ideal candidates are clinically stable COPD patients aged 45-55 with specific symptoms related to their condition.
Not a fit: Patients with a history of deep venous thrombosis, bleeding disorders, or those with implantable devices may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could enhance respiratory function and mobility in COPD patients, improving their quality of life.
How similar studies have performed: While similar approaches have been explored, this specific application of electrical stimulation in COPD patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient undergoes four main clinical criteria for the diagnosis of RLS according to the international restless leg syndrome study group (IRLSSG) including 1. an urge to move legs that is usually associated with paresthesia. 2. alleviation of the symptoms by moving the legs. 3. aggravation or exacerbation of the symptoms particularly at rest or during sitting or lying down in the bed. 4. worsening of the signs at night. patients with diagnosed with grade I and grade II COPD their ages ranged between 45-55 o All patients will be clinically and medically stable when attending the study Exclusion Criteria: * History of Deep venous thrombosis * History of Bleeding disorders * Have an implantable device like a pacemaker * Recent Infected wound * History of allergic response to the electrodes, gel or tape * patients who participating in any other exercise program * Loss of sensation or numbness
Where this trial is running
Dokki
- Faculty of Physical Therapy — Dokki, Egypt (Recruiting)
Study contacts
- Study coordinator: mushabab alahmari, phd
- Email: malahmarirrt@gail.com
- Phone: 563920029
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.